Selected Publication:
SHR
Neuro
Cancer
Cardio
Lipid
Metab
Microb
Böhm, M; Mahfoud, F; Ukena, C; Hoppe, UC; Narkiewicz, K; Negoita, M; Ruilope, L; Schlaich, MP; Schmieder, RE; Whitbourn, R; Williams, B; Zeymer, U; Zirlik, A; Mancia, G; GSR Investigators.
First report of the Global SYMPLICITY Registry on the effect of renal artery denervation in patients with uncontrolled hypertension.
HYPERTENSION. 2015; 65(4): 766-774.
Doi: 10.1161/HYPERTENSIONAHA.114.05010
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Co-authors Med Uni Graz
-
Zirlik Andreas
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
-
This study aimed to assess the safety and effectiveness of renal denervation using the Symplicity system in real-world patients with uncontrolled hypertension (NCT01534299). The Global SYMPLICITY Registry is a prospective, open-label, multicenter registry. Office and 24-hour ambulatory blood pressures (BPs) were measured. Change from baseline to 6 months was analyzed for all patients and for subgroups based on baseline office systolic BP, diabetic status, and renal function; a cohort with severe hypertension (office systolic pressure, ≥160 mm Hg; 24-hour systolic pressure, ≥135 mm Hg; and ≥3 antihypertensive medication classes) was also included. The analysis included protocol-defined safety events. Six-month outcomes for 998 patients, including 323 in the severe hypertension cohort, are reported. Mean baseline office systolic BP was 163.5±24.0 mm Hg for all patients and 179.3±16.5 mm Hg for the severe cohort; the corresponding baseline 24-hour mean systolic BPs were 151.5±17.0 and 159.0±15.6 mm Hg. At 6 months, the changes in office and 24-hour systolic BPs were -11.6±25.3 and -6.6±18.0 mm Hg for all patients (P<0.001 for both) and -20.3±22.8 and -8.9±16.9 mm Hg for those with severe hypertension (P<0.001 for both). Renal denervation was associated with low rates of adverse events. After the procedure through 6 months, there was 1 new renal artery stenosis >70% and 5 cases of hospitalization for a hypertensive emergency. In clinical practice, renal denervation resulted in significant reductions in office and 24-hour BPs with a favorable safety profile. Greater BP-lowering effects occurred in patients with higher baseline pressures.
URL: www.clinicaltrials.gov. Unique identifier: NCT01534299.
© 2015 American Heart Association, Inc.
- Find related publications in this database (using NLM MeSH Indexing)
-
Blood Pressure - physiology
-
Blood Pressure Monitoring, Ambulatory -
-
Female -
-
Follow-Up Studies -
-
Humans -
-
Hypertension - physiopathology
-
Hypertension - surgery
-
Male -
-
Middle Aged -
-
Prospective Studies -
-
Registries -
-
Renal Artery - innervation
-
Sympathectomy - methods
-
Sympathetic Nervous System - physiopathology
-
Sympathetic Nervous System - surgery
-
Time Factors -
-
Treatment Outcome -
- Find related publications in this database (Keywords)
-
denervation
-
hypertension
-
sympathetic nervous system